期刊文献+

血小板膜糖蛋白Ⅱb/Ⅲa受体与子痫前期 被引量:1

Relationship Between Platelet Membrane Glycoprotein Ⅱb/Ⅲa Receptor and Preeclampsia
下载PDF
导出
摘要 糖蛋白Ⅱb/Ⅲa(glycoproteinⅡb/Ⅲa,GPⅡb/Ⅲa)受体是血小板膜上最丰富的一种蛋白,在血小板聚集、血栓形成过程中起关键性调节作用。子痫前期是一种病因不明伴有多系统功能障碍的病理妊娠,表现为高血压、蛋白尿、高凝血、高纤溶倾向,是围产期孕产妇死亡的主要原因,又是产妇远期并发心脑血管疾病的高危因素。GPⅡb/Ⅲa受体在子痫前期发病过程中起"承前启后"的调节作用,有可能为子痫前期的病因探索、临床治疗提供新的突破。 GPⅡb/Ⅲa receptor is the most redundant glycoprotein on platelet membrane,and palys a critical role in the process of platelet aggregation and thrombosis.Preeclampsia is a pathogestation with polysystem imbalance,characterized with hypertension,proteinuria,hypercoagulation,hyperfibrinolysis tendency,and is associated with high maternal high morbidity and mortality and parturient cardiovascular and cerebrovascular disorders in long term.GPⅡb/Ⅲa receptor is a key component in the process of preeclampsia invasion,which could provide original breakthrough for its etiopathogenisis and clinical therapy.
出处 《国际妇产科学杂志》 CAS 2010年第1期27-30,共4页 Journal of International Obstetrics and Gynecology
关键词 糖蛋白Ⅱb/Ⅲa 整合素αⅡbβ3 子痫前期 血栓形成 Glycoprotein Ⅱb/Ⅲa Integrin αⅡbβ3 Preeclampsia Thrombosis
  • 相关文献

参考文献20

  • 1Shen WZ, Ding QL, Jin PP, et al. A novel Pro126His beta propeller mutation in integrin alphaⅡb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticalum to Golgi [J]. Blood Cells Mol Dis, 2009, 42( 1 ): 44-50.
  • 2Rex S, Freedman JE. Chapter 13-Inhibition of platelet function by the endothelium [ M ]//Michelson AD. Platelets. 2nd ed. USA: Academic Press, 2006: 251-279.
  • 3Cho J, Mosher DF. Enhancement of thrombogenesis by plasma fibroneetin cross-linked to fibrin and assembled in platelet thrombi [J]. Blood, 2006, 107(9): 3555-3563.
  • 4Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy [J]. J Am Coil Cardiol, 2008, 52(3 ): 171-180.
  • 5Oksala NK, Heikkinen M, Mikkelsson J, et al. Smoking and the platelet fibrinogen receptor glycoprotein Ⅱb/ⅢA PIA 1/A2 polymorphism interact in the risk of lacunar stroke and midterm survival [J ]. Stroke, 2007, 38 (1): 50-55.
  • 6Lagererantz J, Bergman M, Lundman P, et al. No evidence that the PLA1/PLA2 polymorphism of platelet glyeoprotein Ⅲa is implicated in angiographicany characterized coronary atherosclerosis and premature myocardial infarction [J]. Blood Coagul Fibrinolysis, 2003,14(8):749-753.
  • 7Sibai B, Dekker G, Kupferminc M. Pre-eclampsia[J]. Lancet, 2005, 365 ( 9461 ): 785-799.
  • 8Chelbi ST, Vaiman D. Genetic and epigenetic factors contribute to the onset ofpreeelampsia [J]. Mol Cell Endocfinol, 2008, 282(1/ 2): 120-129.
  • 9Aharon A, Brenner B. Mieropartieles and placental hemostasis [J]. Thromb Res, 2009, 123 (Suppl 2): 88-92.
  • 10Gonzalez-Quintero VH, Smarkusky LP, Jimenez JJ, et al. Elevated plasma endothelial microparticles:preeclampsia versus gestational hypertension [J]. Am J Obstet Gynecol, 2004, 191 (4): 1418-1424.

同被引文献14

  • 1王晓霞,李晓钟,刘红林,解军,张悦红,王惠珍,牛勃.AoGDW肽抑制血小板聚集的作用机制[J].中国药理学通报,2007,23(5):626-629. 被引量:8
  • 2Sanchez-Cortes J, Mrksich M. The platelet integrin αⅡ b133 binds to the RGD and AGD motifs in fibrinogen [J]. Chem Biol, 2009,16 (9): 990-1000.
  • 3Comisar WA, Mooney DJ, Linderman JJ. lntegrin organiztion: linking adhesion ligand nanopatterns wittl altered cell responses [J]. J Ther Biol, 2011. 274 (1): 120-130.
  • 4Calvete J J, Marcinkiewicz C, Munle6n D, et al. Snake wmom disintegrins: evolution of" structure and function [J]. Toxicon, 2005, 45 ( 8 ) : 1063-1074.
  • 5Szemraj J, Zakrzeska A, Brown G, et al. New derivalive of staphylokinase SAK-RGD-K2-Hirul exerts thrnmbolytic effects in the arterial thrombosis model in rats [J]. Phannacol Rep, 2011, 63 (5): 1169-1179.
  • 6Jones ML, Harper MT, Aitken EW, et ol. RGD-ligand mime- tic antagonists of integrin alphalIbbeta3 paradoxically enhance GPVI-induced human platelet activation [J]. J Thromb Hae- most, 2010, 8 (3): 567-576.
  • 7Zhang JG, Kra jden OB, Kainthan RK, et all. Conjugation to hyperbranched polyglycerols improves RGD-mediated inhibi- tion of platelet function in vitro [J]. Bioconjug Chem, 2008, 19 (6): 1241-1247.
  • 8Ahrens IG, Moran N, Aylward K, et ol. Evidence for a differential functional regulation of the twoβ3-integrins αVβ and aⅡbβ3 [J]. Exp Cell Res, 2006, 312 (6): 925-937.
  • 9Russo MA, Paolillo M, Sanchez-Hernandez Y, et al. A small-molecule RGD-integrin antagonist inhibits cell adhesion, cell migration and induces anoikis in glioblastoma cells [J]. Int J Oncol, 2013, 42 (1): 83-92.
  • 10Chen ZY, Deng JX, Zhao Y, et al. Cyclic RGD peptide- modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats [J]. Int J Nanomedicine, 2012, 7 (3): 3803-3811.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部